A conversation with Dr. Alex Colville (@AlexJColville), co-founder and GP of Age1, the first longevity fund. He studied the biology of aging for his PhD in Genetics at Stanford and has deployed more than $100M into longevity and biotech. We discuss how Anthropic & OpenAi are suddenly buying biotech startups and racing to solve Ai drug discovery. And why tech billionaires + crypto founders are both allocating significant capital to this sector. Enjoy! 00:00 Intro 01:45 Chatgpt Moment for Biotech 03:57 Why Longevity Is Exploding Now 07:33 Exciting Bio Investment Areas 11:09 Growing Fresh Cells From Stem Cells 16:07 Epigenetic Reprogramming 19:50 Sponsored by Kraken 20:56 Reversible Cryopreservation 22:56 NewLimit's Big Bet 28:15 Is There One Cure? 30:10 Peptides Real or Hype? 34:30 What AI Is Unlocking in Biotech 36:54 Zero-Person Biotech? 40:35 Ai Labs Becoming Biotechs 44:06 Open Source vs Secrecy 47:18 Crypto Founders Longevity Bets 50:05 The Story Behind Age1 55:30 Moonshots 1:00:55 Dogs Living Forever 1:03:31 Manhattan Project for Aging 1:06:38 Contrarian Biotech 1:09:07 Holy Grail Bet